Mind Medicine Reports Q3 GAAP EPS of -$0.46, Exceeding Analyst Expectations
Mind Medicine (DFTX) reported third-quarter financial results featuring a GAAP earnings per share (EPS) of -$0.46, which outperformed market expectations by $0.10. Despite the net loss, the company demonstrated significant growth in its liquidity position. As of September 30, 2026, Mind Medicine's cash, cash equivalents, and investments reached approximately $1.05 billion. This represents a substantial increase from the $411.6 million reported as of December 31, 2025, providing the company with a strengthened capital base for ongoing operations.
Tickers: $DFTX
Topics: cash position earnings beat GAAP EPS
Read the full article at Seeking Alpha
Part of the story St. Joe Reports Q3 GAAP EPS of $0.65 and Revenue of $156.2 Million (30 articles)